PSB-SB1202 is a benzylcoumarin compound that acts as an agonist at the major cannabinoid (CB) receptors, with EC50 values of 56 and 14 nM at CB1 and CB2, respectively. It is a weak antagonist at the CB receptor GPR55, with an IC50 value of 6.4 μM. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
